Cns Pharmaceuticals, Inc.
CNSP
Revenue
0.00
0.000.00%
-Assets
2.47M
▲808.39k▲48.67%
3 Months ChangeLiabilities
6.76M
▲671.47k▲11.02%
3 Months ChangeFree Cash Flow
-3.08M
▲234.53k▲7.08%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001683168-24-007533
2024-10-24
Form 8-K
ID: 0001683168-24-007371
2024-10-23
Form 8-K
ID: 0001683168-24-007304
2024-09-18
Form 8-K
ID: 0001683168-24-006495
2024-09-12
Form 8-K
ID: 0001683168-24-006318
2024-08-14
Form 10-Q
ID: 0001683168-24-005711
2024-08-07
Form 8-K
ID: 0001683168-24-005311
2024-07-30
Form 8-K
ID: 0001683168-24-005145
2024-07-30
Form 8-K
ID: 0001683168-24-005118
2024-07-26
Form 8-K
ID: 0001683168-24-005070